Search research articles
Contact Us
Filters
Showing results (1-10 of 148) with videos related to
Page
of 15
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
January 4, 2022
[Elucidation of Phenomena Involving Cyanobacteria in Freshwater Ecosystem by Chemically Ecological Approach]
Ken-Ichi Harada
Chemical & Pharmaceutical Bulletin
|
August 12, 2004
Production of secondary metabolites by freshwater cyanobacteria
Ken-Ichi Harada
Toxicon : Official Journal of the International Society on Toxinology
|
April 28, 2004
Proteomics approach on microcystin binding proteins in mouse liver for investigation of microcystin toxicity
Susumu Imanishi, Ken-ichi Harada
The Journal of Antibiotics
|
February 17, 2009
Microbial degradation of cyclic peptides produced by bacteria
Hajime Kato, Kiyomi Tsuji, Ken-ichi Harada
Mass Spectrometry (Tokyo, Japan)
|
March 4, 2024
Mobilize a Proton to Transform the Collision-Induced Dissociation Spectral Pattern of a Cyclic Peptide
Takemichi Nakamura, Yayoi Hongo, Ken-Ichi Harada
International Cancer Conference Journal
|
June 1, 2019
Promising response to axitinib rechallenge for metastatic renal cell carcinoma after progression on prior axitinib: report of two cases
Hideaki Miyake, Ken-Ichi Harada, Masato Fujisawa
Journal of Chromatography. A
|
June 8, 2007
Elution behavior of diaminopimelic acid and related diamino acids using the advanced Marfey's method
Yoshito Kawasaki, Yuriko Nozawa, Ken-ichi Harada
Optics Letters
|
April 6, 2007
Four-wave parametric oscillation in sodium vapor by electromagnetically induced diffraction
Ken-ichi Harada, Minoru Ogata, Masaharu Mitsunaga
Environmental Toxicology
|
November 15, 2007
Phosphoprotein analysis for investigation of in vivo relationship between protein phosphatase inhibitory activities and acute hepatotoxicity of microcystin-LR
Masahiko Tachi, Susumu Y Imanishi, Ken-Ichi Harada
Clinical Genitourinary Cancer
|
July 31, 2016
Assessment of Efficacy, Safety, and Quality of Life of 124 Patients Treated With Axitinib as Second-Line Therapy for Metastatic Renal-Cell Carcinoma: Experience in Real-World Clinical Practice in Japan
Hideaki Miyake, Ken-Ichi Harada, Seiichiro Ozono, et al.
Page
of 15
Search research articles
Search
Showing results (1-10 of 148) with videos related to
Sort By:
Page
of 15
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
January 4, 2022
[Elucidation of Phenomena Involving Cyanobacteria in Freshwater Ecosystem by Chemically Ecological Approach]
Ken-Ichi Harada
Chemical & Pharmaceutical Bulletin
|
August 12, 2004
Production of secondary metabolites by freshwater cyanobacteria
Ken-Ichi Harada
Toxicon : Official Journal of the International Society on Toxinology
|
April 28, 2004
Proteomics approach on microcystin binding proteins in mouse liver for investigation of microcystin toxicity
Susumu Imanishi, Ken-ichi Harada
The Journal of Antibiotics
|
February 17, 2009
Microbial degradation of cyclic peptides produced by bacteria
Hajime Kato, Kiyomi Tsuji, Ken-ichi Harada
Mass Spectrometry (Tokyo, Japan)
|
March 4, 2024
Mobilize a Proton to Transform the Collision-Induced Dissociation Spectral Pattern of a Cyclic Peptide
Takemichi Nakamura, Yayoi Hongo, Ken-Ichi Harada
International Cancer Conference Journal
|
June 1, 2019
Promising response to axitinib rechallenge for metastatic renal cell carcinoma after progression on prior axitinib: report of two cases
Hideaki Miyake, Ken-Ichi Harada, Masato Fujisawa
Journal of Chromatography. A
|
June 8, 2007
Elution behavior of diaminopimelic acid and related diamino acids using the advanced Marfey's method
Yoshito Kawasaki, Yuriko Nozawa, Ken-ichi Harada
Optics Letters
|
April 6, 2007
Four-wave parametric oscillation in sodium vapor by electromagnetically induced diffraction
Ken-ichi Harada, Minoru Ogata, Masaharu Mitsunaga
Environmental Toxicology
|
November 15, 2007
Phosphoprotein analysis for investigation of in vivo relationship between protein phosphatase inhibitory activities and acute hepatotoxicity of microcystin-LR
Masahiko Tachi, Susumu Y Imanishi, Ken-Ichi Harada
Clinical Genitourinary Cancer
|
July 31, 2016
Assessment of Efficacy, Safety, and Quality of Life of 124 Patients Treated With Axitinib as Second-Line Therapy for Metastatic Renal-Cell Carcinoma: Experience in Real-World Clinical Practice in Japan
Hideaki Miyake, Ken-Ichi Harada, Seiichiro Ozono, et al.
Page
of 15